IMMX Stock Analysis: Buy, Sell, or Hold?
IMMX - Immix Biopharma, Inc. Common Stock
$9.33
0.91 (10.81%)
▲
5d:
+10.55%
30d:
-10.72%
90d:
-1.58%
BUY
HIGH Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 14, 2026
8d
Get Alerted When IMMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IMMX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: IMMX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: IMMX is currently trading at $9.33, which is considered fair relative to its 30-day fair value range of $8.73 to $10.80.
Technical Outlook: Technically, IMMX is showing sideways momentum. Immediate support is located at $7.83, while resistance sits at $9.79. The stock is showing strong short-term momentum, up 10.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.91 (+113.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMMX is showing sideways momentum. Immediate support is located at $7.83, while resistance sits at $9.79. The stock is showing strong short-term momentum, up 10.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.91 (+113.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.73 -
$10.80
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.8%)
- BULLISH: Trading 113.4% below Wall St target ($19.91)
Trading Range Analysis
30-Day Trading Range
$8.73 -
$10.80
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.83
Resistance Level
$9.79
Current Trend
Sideways
Technical data as of
Aug 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.11
Wall Street Target
$19.91
(+113.4%)
Share & Embed Analysis
Last updated: August 04, 2026 11:18 PM ET
Data refreshes hourly during market hours. Next update: 12:18 AM
Data refreshes hourly during market hours. Next update: 12:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 55 HOLD |
